According to Drugs.com, the price of two subcutaneous kits of Humira can cost between $7,299 to $14,588, depending on dosage, and the biosimilars launched this first week in July aim to offer a ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter ...

At the moment Cyltezo's label cover most but not all of Humira's approved indications, and Boehringer's drug is also available only as a single-dose prefilled syringe for subcutaneous injection ...

Credit: Celltrion. Yuflyma, a tumor necrosis factor blocker, was approved in May 2023 as a biosimilar to Humira. Similar PK, efficacy, safety, and immunogenicity data were observed between the ...

It is the ninth Humira biosimilar approved by the FDA and the fourth to receive interchangeability status. The FDA has accepted Yuflyma as an interchangeable biosimilar to adalimumab for the ...

If approved, this option would allow patients to begin treatment with under-the-skin or subcutaneous (SC ... for its blockbuster immunology drug Humira (adalimumab), when its US patent expired ...